全文获取类型
收费全文 | 3327篇 |
免费 | 216篇 |
国内免费 | 119篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 40篇 |
妇产科学 | 50篇 |
基础医学 | 384篇 |
口腔科学 | 33篇 |
临床医学 | 262篇 |
内科学 | 262篇 |
皮肤病学 | 34篇 |
神经病学 | 139篇 |
特种医学 | 80篇 |
外科学 | 269篇 |
综合类 | 344篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 337篇 |
眼科学 | 15篇 |
药学 | 651篇 |
2篇 | |
中国医学 | 590篇 |
肿瘤学 | 139篇 |
出版年
2024年 | 20篇 |
2023年 | 75篇 |
2022年 | 159篇 |
2021年 | 196篇 |
2020年 | 138篇 |
2019年 | 127篇 |
2018年 | 118篇 |
2017年 | 111篇 |
2016年 | 129篇 |
2015年 | 139篇 |
2014年 | 264篇 |
2013年 | 243篇 |
2012年 | 213篇 |
2011年 | 215篇 |
2010年 | 169篇 |
2009年 | 146篇 |
2008年 | 141篇 |
2007年 | 124篇 |
2006年 | 118篇 |
2005年 | 80篇 |
2004年 | 67篇 |
2003年 | 63篇 |
2002年 | 43篇 |
2001年 | 44篇 |
2000年 | 29篇 |
1999年 | 46篇 |
1998年 | 28篇 |
1997年 | 21篇 |
1996年 | 22篇 |
1995年 | 33篇 |
1994年 | 28篇 |
1993年 | 24篇 |
1992年 | 23篇 |
1991年 | 15篇 |
1990年 | 18篇 |
1989年 | 13篇 |
1987年 | 13篇 |
1986年 | 14篇 |
1985年 | 20篇 |
1984年 | 28篇 |
1983年 | 9篇 |
1982年 | 13篇 |
1981年 | 9篇 |
1980年 | 11篇 |
1979年 | 14篇 |
1978年 | 11篇 |
1977年 | 17篇 |
1976年 | 9篇 |
1974年 | 9篇 |
1973年 | 11篇 |
排序方式: 共有3662条查询结果,搜索用时 10 毫秒
91.
《Journal of intellectual & developmental disability》2013,38(4):344-355
AbstractBackground?Social inclusion is a widely acknowledged goal; who is best positioned to provide support and how support is delivered are key questions. Using Active Mentoring training, members of community groups mentored a person with intellectual disability and supported their inclusion in that group.Methods?Interviews with 14 mentors explored their experiences of supporting a previously unknown person with intellectual disability to participate in their community group.Findings?The core theme was No Different From Us. Mentors saw beyond the disability, they valued others, were community leaders, and had intrinsic qualities. With some basic orientation to the task, mentors were able to support the inclusion of their mentee in the group.Conclusion?Community members are willing to support people with intellectual disability to join their community groups. The Active Mentoring training is one way of harnessing the goodwill of community groups and their members to include people with intellectual disability to participate on an individual basis in community groups. 相似文献
92.
Lara Bellardita Tiziana Rancati Maria Francesca Alvisi Daniela Villani Tiziana Magnani Cristina Marenghi Nicola Nicolai Giuseppe Procopio Sergio Villa Roberto Salvioni Riccardo Valdagni 《European urology》2013
Background
Active surveillance (AS) is emerging as an alternative approach to limit the risk of overtreatment and impairment of quality of life (QoL) in patients with low-risk localised prostate cancer. Although most patients report high levels of QoL, some men may be distressed by the idea of living with untreated cancer.Objective
To identify factors associated with poor QoL during AS.Design, setting, and participants
Between September 2007 and March 2012, 103 patients participated in the Prostate Cancer Research International Active Surveillance (PRIAS) QoL study. Mental health (Symptom Checklist-90), demographic, clinical, and decisional data were assessed at entrance in AS. Health-related QoL (HRQoL) Functional Assessment of Cancer Therapy-Prostate version and Mini-Mental Adjustment to Cancer outcomes were assessed after 10 mo of AS.Outcome measurements and statistical analysis
Multivariate logistic regression models were used to identify predictors of low (<25th percentile) HRQoL, adjustment to cancer, and a global QoL index at 10 mo after enrolment.Results and limitations
The mean age of the study patients was 67 yr (standard deviation: ±7 yr). Lack of partner (odds ratio [OR]: 0.08; p = 0.009) and impaired mental health (OR: 1.2, p = 0.1) were associated with low HRQoL (p = 0.006; area under the curve [AUC]: 0.72). The maladaptive adjustment to cancer (p = 0.047; AUC: 0.60) could be predicted by recent diagnosis (OR: 3.3; p = 0.072). Poor global QoL (overall p = 0.02; AUC: 0.85) was predicted by impaired mental health (OR: 1.16; p = 0.070) and time from diagnosis to enrolment in AS <5 mo (OR: 5.52; p = 0.009). Influence of different physicians on the choice of AS (OR: 0.17; p = 0.044), presence of a partner (OR: 0.22; p = 0.065), and diagnostic biopsy with >18 core specimens (OR: 0.89; p = 0.029) were predictors of better QoL. Limitations of this study were the small sample size and the lack of a control group.Conclusions
Factors predicting poor QoL were lack of a partner, impaired mental health, recent diagnosis, influence of clinicians and lower number of core samples taken at diagnostic biopsy. Educational support from physicians and emotional/social support should be promoted in some cases to prevent poor QoL. 相似文献93.
Roderick C.N. van den Bergh Peter C. Albertsen Chris H. Bangma Stephen J. Freedland Markus Graefen Andrew Vickers Henk G. van der Poel 《European urology》2013
Context
Delaying definitive therapy unfavourably affects outcomes in many malignancies. Diagnostic, psychological, and logistical reasons but also active surveillance (AS) strategies can lead to treatment delay, an increase in the interval between the diagnosis and treatment of prostate cancer (PCa).Objective
To review and summarise the current literature on the impact of treatment delay on PCa oncologic outcomes.Evidence acquisition
A comprehensive search of PubMed and Embase databases until 30 September 2012 was performed. Studies comparing pathologic, biochemical recurrence (BCR), and mortality outcomes between patients receiving direct and delayed curative treatment were included. Studies presenting single-arm results following AS were excluded.Evidence synthesis
Seventeen studies were included: 13 on radical prostatectomy, 3 on radiation therapy, and 1 combined both. A total of 34 517 PCa patients receiving radical local therapy between 1981 and 2009 were described. Some studies included low-risk PCa only; others included a wider spectrum of disease. Four studies found a significant effect of treatment delay on outcomes in multivariate analysis. Two included low-risk patients only, but it was unknown whether AS was applied or repeat biopsy triggered active therapy during AS. The two other studies found a negative effect on BCR rates of 2.5–9 mo delay in higher risk patients (respectively defined as any with T ≥2b, prostate-specific antigen >10, Gleason score >6, >34–50% positive cores; or D’Amico intermediate risk-group). All studies were retrospective and nonrandomised. Reasons for delay were not always clear, and time-to-event analyses may be subject to bias.Conclusions
Treatment delay of several months or even years does not appear to affect outcomes of men with low-risk PCa. Limited data suggest treatment delay may have an impact on men with non–low-risk PCa. Most AS protocols suggest a confirmatory biopsy to avoid delaying treatment in those who harbour higher risk disease that was initially misclassified. 相似文献94.
96.
目的系统了解中药有效成分血浆蛋白结合率国内外研究进展,并探讨相关规律,为相关研究提供借鉴和参考,并为预测中药与其他药物联用时,是否会发生血浆蛋白结合介导的药物相互作用提供依据。方法通过文献检索,对中药有效成分血浆蛋白结合率的相关报道进行分析和总结。结果中药有效成分血浆蛋白结合率的研究国内外已有较多报道,显示不同结构的成分血浆蛋白结合率有较大差异,与结构类别、官能团位置、官能团数量等因素有关,且呈现一定的规律性。结论很多中药成分具有较高的血浆蛋白结合率,这些中药及其制剂与高血浆蛋白结合率的药物联用时,应关注可能会因为竞争血浆蛋白结合而产生药物相互作用,以保障患者用药安全。 相似文献
97.
Liu Y.Zhong C.Huang L.Lü X. 《中国感染与化疗杂志》2016,(1):41-44
Objective To report two cases of adult-onset chronic active Epstein-Barr virus (CAEBV) infection, and review the relevant literature to improve the awareness of this disease. Methods The clinical data of 2 CAEBV patients were analyzed retrospectively. We also summarized the current understanding of CAEBV and described recent progress of CAEBV research. Results Two patients were diagnosed with CAEBV. The follow-up data showed that viral load was still detectable in one patient. The other patient lost to follow up. Conclusions The clinical presentations of CAEBV are diverse and nonspecific. The disease is progressive and more aggressive than the childhood-onset cases. The viral load in peripheral blood plays an important role in assessing patients’ conditions and planning therapeutic strategies. Viral load combined with tissue biopsy is an effective way for early diagnosis of this disease. © by Editorial Department of Chinese Journal of Infection and Chemotherapy. 相似文献
98.
This study investigated the joint influence of trait social anxiety and evaluative threat on psychological and cardiovascular responses to active coping situations. Fifty-two normotensive female students characterized as either high or low in trait social anxiety performed a mental arithmetic task and a speech task requiring persuasive behavior in a context of high or low evaluative threat. Trait social anxiety exerted a substantial influence on cardiovascular reactivity. High socially anxious individuals overall exhibited greater heart rate reactivity. For systolic and diastolic blood pressure enhanced reactivity of socially anxious individuals was confined to low evaluative threat. At high levels of evaluative threat no group differences were observed due to somewhat attenuated reactivity in high compared to low socially anxious individuals. Cognitive appraisals and affective arousal were not found to mediate the effects of social anxiety on cardiovascular reactivity. Results were attributed to differences in effort expenditure rather than experienced anxiety. 相似文献
99.
Jiali Chen Yuqi Chen Wencong Huang Hanning Wang Yang Du Subin Xiong 《Journal of pharmaceutical sciences》2018,107(9):2366-2376
The objectives of this study were to explore sodium dodecyl sulfate (SDS) and Soluplus on the crystallization inhibition and dissolution of felodipine (FLDP) extrudates by bottom-up and top-down approaches. FLDP extrudates with Soluplus and SDS were prepared by hot melt extrusion, and characterized by polarized light microscopy, differential scanning calorimetry, and fourier transform infrared spectroscopy. Results indicated that Soluplus inhibited FLDP crystallization, and the whole amorphous solid dispersions (ASDs) were binary FLDP-Soluplus (1:3) and ternary FLDP-Soluplus-SDS (1:2:0.15~0.3 and 1:3:0.2~0.4) extrudates. Internal SDS (5%-10%) decreased glass transition temperatures of FLDP-Soluplus-SDS ternary ASDs without presenting molecular interactions with FLDP or Soluplus. The enhanced dissolution rate of binary or ternary Soluplus-rich ASDs in the nonsink condition of 0.05% SDS was achieved. Bottom-up approach indicated that Soluplus was a much stronger crystal inhibitor to the supersaturated FLDP in solutions than SDS. Top-down approach demonstrated that SDS enhanced the dissolution of Soluplus-rich ASDs via wettability and complexation with Soluplus to accelerate the medium uptake and erosion kinetics of extrudates, but induced FLDP recrystallization and resulted in incomplete dissolution of FLDP-rich extrudates. In conclusion, top-down approach is a promising strategy to explore the mechanisms of ASDs' dissolution, and small amount of SDS enhances the dissolution rate of polymer-rich ASDs in the nonsink condition. 相似文献
100.
Timothy Pas Bjorn Vergauwen Guy Van den Mooter 《International journal of pharmaceutics》2018,535(1-2):47-58
Biopolymers have rarely been used so far as carriers in the formulation of amorphous solid dispersions (ASD) to overcome poor solubility of active pharmaceutical ingredients (APIs). In an attempt to enlarge our knowledge on this topic, gelatin, type 50PS was selected. A screening study was initiated in which twelve structurally different poorly soluble biopharmaceutical classification system (BCS) Class II drugs (carbamazepine, cinnarizine, diazepam, itraconazole, nifedipine, indomethacin, darunavir (ethanolate), ritonavir, fenofibrate, griseofulvin, ketoconazole and naproxen) were selected for evaluation. Solid dispersions of five different drug loadings of these twelve compounds were prepared by lyophilization and evaluated for their solid state properties by mDSC and XR(P)D, and in vitro dissolution performance. Even without any process optimization it was possible to form either fully amorphous or partially amorphous systems, depending on the API and API to carrier ratio. Hence in this respect, gelatin 50PS behaves as any other carrier. Dissolution of the API from the solid dispersions significantly exceeded that of their crystalline counterparts. This study shows the potential of gelatin as a carrier to formulate amorphous solid dispersions. 相似文献